MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway | Zendy

Huimei Yang | Zendy; Zhenzhen Song | Zendy; Xia Wu | Zendy; YiLei Wu | Zendy; Chengxia Liu | Zendy

Open Access

<p>MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway</p>

Author(s) -

Huimei Yang,

Zhenzhen Song,

Xia Wu,

YiLei Wu,

Chengxia Liu

Publication year - 2019

Publication title -

oncotargets and therapy

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.054

H-Index - 60

ISSN - 1178-6930

DOI - 10.2147/ott.s204715

Subject(s) - downregulation and upregulation , microrna , cancer research , flow cytometry , cell growth , clone (java method) , pi3k/akt/mtor pathway , biology , cell culture , protein kinase b , u87 , apoptosis , microbiology and biotechnology , signal transduction , glioma , gene , genetics

An increasing number of studies have documented that dysregulation of microRNAs (miRNAs) is common in glioblastoma multiforme (GBM). miR-652 is aberrantly expressed in various human cancers and plays important roles in numerous cancer-related processes. However, the expression profiles and potential roles of miR-652 in GBM remain largely unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research